2022. Bio Studies of Novel Macrocyclic Sulfazan and Linear Sulfazan (Creation, Analysis and Anticancer Assessment). Journal of Pharmaceutical Negative Results. 13, 4 (Oct. 2022), 351–363. DOI:https://doi.org/10.47750/pnr.2022.13.04.043.